Luc Villeneuve has academic and industrial research experience where he managed and collaborated with teams of researchers and administrators through project planning, funding, research and development. Experienced as a manager and an executive, he builds on vision and creative ideas through R&D and delivery of results. Mr.  Villeneuve is a creative thinker skilled in strategic planning and management, with strong problem solving competencies, from discovery to pre-clinical, pre-IND  and IND's. Dynamic, multitasking, tenacious and adept at completing projects on time and within budget, Dr. Villeneuve has built a portfolio of patents for drugs, drug applications, medical devices and cell therapy products which contribute to IMMUNI T success.

Specialist in hematology and medical oncology, Dr Martin Champagne is interested in the transplantation of hematopoietic stem cells, particularly the clinical use of cord blood in unrelated bone marrow transplantation. Dr Champagne is a member of the board of director of Hema-Quebec as a specialist of transfusion medicine, Dr Champagne acts as the hematology laboratory director at IMMUNI T.

Bruno Paquin joined IMMUNI T in April 2011. Dr. Paquin has worked in the biotech industry for over ten years in R&D and business development. He brings experience in business development and management at Immuni T. Prior to Immuni T, Dr. Paquin was Executive Director, Business Development at Genizon Biosciences where he has been critical to the progress of Genizon’s discovery programs as well as heading the business development activities. Dr. Paquin obtained his Ph.D. in biochemistry from the Université de Montréal and has 20 years of experience in the field of molecular biology.

Sole practitioner with special interest in corporate and commercial matters as well as intellectual property protection, trade-marks and scientific research. Personal interest in ethics, clinical research and private information rights protection and vigilance. Former VP-Legal Phoenix International Life Sciences and MDS Pharma Services and former Legal Counsel Pfizer Canada Inc. Currently holds the position of legal counsel and secretary for a number of clients. Also holds the position of Executive Director of the Canadian Association of Blue Cross Plans. Mr Lesage acts as a senior corporate and legal advisor at IMMUNI T.